Correlation Between Aquestive Therapeutics and Alkermes Plc
Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and Alkermes Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and Alkermes Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aquestive Therapeutics and Alkermes Plc, you can compare the effects of market volatilities on Aquestive Therapeutics and Alkermes Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of Alkermes Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and Alkermes Plc.
Diversification Opportunities for Aquestive Therapeutics and Alkermes Plc
-0.54 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Aquestive and Alkermes is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and Alkermes Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alkermes Plc and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with Alkermes Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alkermes Plc has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and Alkermes Plc go up and down completely randomly.
Pair Corralation between Aquestive Therapeutics and Alkermes Plc
Given the investment horizon of 90 days Aquestive Therapeutics is expected to under-perform the Alkermes Plc. In addition to that, Aquestive Therapeutics is 1.84 times more volatile than Alkermes Plc. It trades about -0.04 of its total potential returns per unit of risk. Alkermes Plc is currently generating about 0.3 per unit of volatility. If you would invest 2,842 in Alkermes Plc on November 9, 2024 and sell it today you would earn a total of 297.00 from holding Alkermes Plc or generate 10.45% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aquestive Therapeutics vs. Alkermes Plc
Performance |
| Timeline |
| Aquestive Therapeutics |
| Alkermes Plc |
Aquestive Therapeutics and Alkermes Plc Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aquestive Therapeutics and Alkermes Plc
The main advantage of trading using opposite Aquestive Therapeutics and Alkermes Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, Alkermes Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alkermes Plc will offset losses from the drop in Alkermes Plc's long position.| Aquestive Therapeutics vs. Evoke Pharma | Aquestive Therapeutics vs. Dynavax Technologies | Aquestive Therapeutics vs. Amphastar P | Aquestive Therapeutics vs. Lantheus Holdings |
| Alkermes Plc vs. Intracellular Th | Alkermes Plc vs. Ironwood Pharmaceuticals | Alkermes Plc vs. Pacira BioSciences, | Alkermes Plc vs. ANI Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |